Article Text

Download PDFPDF
Peritoneal tuberculosis simulating advanced ovarian carcinoma: is clinical impression sufficient to administer neoadjuvant chemotherapy for advanced ovarian cancer?
  1. A. Gurbuz,
  2. A. Karateke,
  3. C. Kabaca,
  4. G. Kir and
  5. E. Cetingoz
  1. Department of Obstetrics and Gynecology, Zeynep Kamil Women and Children Diseases Education and Research Hospital, Uskudar, Istanbul, Turkey
  1. Address correspondence and reprint requests to: Dr Ayse Gurbuz, MD, Selamicesme, Bagdat Cad. Fahriye Apt. No: 179/2, Kat: 2 Daire: 7, 81030 Kadikoy, Istanbul, Turkey. Email: canankabaca{at}


Peritoneal tuberculosis mimics advanced ovarian cancer because of the similarities in clinical signs and symptoms such as ascites, pelvic and abdominal pain and mass, and elevation of serum CA125 level. We have presented four cases of peritoneal tuberculosis that underwent exploratory laparotomy for suspected advanced ovarian cancer during a 3-year period. Definitive diagnosis of tuberculosis was performed at laparotomy in all the cases. The frozen-section analysis seems to be the gold standard in the differential diagnosis. In view of these data, clinical diagnosis of advanced ovarian cancer is not sufficient for administering neoadjuvant chemotherapy. Cytologic or pathologic findings must be consistent with ovarian cancer for candidates who are being considered for neoadjuvant chemotherapy.

  • CA125
  • chemotherapy
  • neoadjuvant
  • ovarian cancer
  • peritoneal tuberculosis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.